Company Financials

Alpine Immune Sciences, Inc. Financials

Swiss franc

business Alpine Immune Sciences, Inc. Company Profile

Main Stock Listing

NASDAQ: ALPN

Market Capitalization $1.03 Billion as of Jan. 1, 2024

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 62.14
Forward PE
Price to Sales TTM CHF98.57
Price to Book MRQ CHF1.12
Enterprise to Revenue 93.66
Enterprise to EBITDA

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin -141.56%
Operating Margin 59.59%
Return on Assets TTM -0.77%
Return on Equity TTM -1.59%

Income Statement

Revenue TTM CHF782,000
Revenue per Share TTM CHF0.09
Quarterly Revenue Growth -51.00%
Gross Profit TTM CHF782,000
EBITDA CHF0
Net Income to Common TTM CHF-1,107,000
Diluted EPS TTM CHF-0.13
Quarterly Earnings Growth YoY -65.40%

Balance Sheet

Total Cash MRQ CHF3,026,000
Total Cash per Share MRQ CHF0.36
Total Debt MRQ CHF
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 15.79
Book Value per Share MRQ CHF8.01

Cash Flow

Operating Cash Flow TTM CHF800,000
Levered Free Cash Flow TTM CHF-498,500

ALPN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 8,521,749
Float Shares 1,554,964
Avg 10 Volume 2,547
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 66.54%
% Held by Institutions 0.00%

Stock Price Summary

Beta 0.34
Fifty Two Week Low CHF6.90
Fifty Two Week High CHF9.45
Fifty Two Week Change 15.08%
Day 50 MA CHF8.82
Day 200 MA CHF8.12

Dividends and Splits

Forward Annual Dividend Rate CHF12.00
Forward Annual Dividend Yield 134.08%
Trailing Annual Dividend Rate CHF3.00
Trailing Annual Dividend Yield 33.52%
Payout Ratio 0.00%
Dividend Date 2023-09-27
Ex Dividend Date 2023-09-25
Last Split Factor
Last Split Date 2004-09-02